Skip to main content

Advertisement

Log in

Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian

  • Original Paper
  • Published:
Journal of Pharmacokinetics and Pharmacodynamics Aims and scope Submit manuscript

Abstract

Population pharmacokinetic (PK) modeling methods can be statistically classified as either parametric or nonparametric (NP). Each classification can be divided into maximum likelihood (ML) or Bayesian (B) approaches. In this paper we discuss the nonparametric case using both maximum likelihood and Bayesian approaches. We present two nonparametric methods for estimating the unknown joint population distribution of model parameter values in a pharmacokinetic/pharmacodynamic (PK/PD) dataset. The first method is the NP Adaptive Grid (NPAG). The second is the NP Bayesian (NPB) algorithm with a stick-breaking process to construct a Dirichlet prior. Our objective is to compare the performance of these two methods using a simulated PK/PD dataset. Our results showed excellent performance of NPAG and NPB in a realistically simulated PK study. This simulation allowed us to have benchmarks in the form of the true population parameters to compare with the estimates produced by the two methods, while incorporating challenges like unbalanced sample times and sample numbers as well as the ability to include the covariate of patient weight. We conclude that both NPML and NPB can be used in realistic PK/PD population analysis problems. The advantages of one versus the other are discussed in the paper. NPAG and NPB are implemented in R and freely available for download within the Pmetrics package from www.lapk.org.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. FDA (1999) FDA guidance for industry: population pharmacokinetics

  2. Beal S, Sheiner L (1982) Estimating population kinetics. Crit Rev Biomed Eng 8(3):95–222

    Google Scholar 

  3. Beal S, Sheiner L (1992) NONMEM User’s Guide. In: Nonlinear mixed effects models for repeated measures. University of California, San Francisco

  4. Lavielle M, Mentré F (2007) Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software. J Pharmacokinet Pharmacodyn 34(2):229–249

    Article  PubMed  CAS  Google Scholar 

  5. D’Argenio D, Schumitzky A, Wang X (2009) ADAPT 5 User’s guide:pharmacokinetic/pharmacodynamic systems analysis Software. Biomedical Simulations Resource, Los Angeles

    Google Scholar 

  6. Wang A, Schumitzky A, DArgenio D (2007) Nonlinear random effects mixture models: maximum likelihood estimation via the EM algorithm. Comput Stat Data Anal 51:6614–6623

    Article  PubMed  Google Scholar 

  7. Wang A, Schumitzky A, DArgenio D (2009) Population pharmacokinet-ic/pharmacodyanamic mixture models via maximum a posteriori estimation. Comput Stat Data Anal 53:3907

    Article  PubMed  Google Scholar 

  8. Lindsay B (1983) The geometry of mixture likelihoods: a general theory. Ann Stat 11:86–94

    Article  Google Scholar 

  9. Mallet A (1986) A maximum likelihood estimation method for random coefficient regression models. Biometrika 73:645–656

    Article  Google Scholar 

  10. Kiefer J, Wolfowitz J (1956) Consistency of the maximum likelihood estimator in the presence of infinitely many incidental parameters. Ann Math Stat 27(4):887–906

    Article  Google Scholar 

  11. Baverel P, Savic R, Karlsson M (2011) Two bootstrapping routines for obtaining imprecision estimates for nonparametric parameter distributions in nonlinear mixed effects models. J Pharmacokinet Pharmacodyn 38(1):63–82

    Article  PubMed  Google Scholar 

  12. Spiegelhalter DJ, Thomas A, Best NG (2004) WinBUGS Version 1.4 User Manual, MRC Biostatistics Unit

  13. Plummer M (2003) JAGS: A program for analysis of Bayesian Graphical Models Using Gibbs Sampling. Proceedings of the 3rd International Workshop on Distributed Statistical Computing (DSC 2003), Vienna

  14. Wakefield J, Walker S (1997) Bayesian nonparametric population models: formulation and comparison with likelihood approaches. J Pharmacokinet Biopharm 25:235–253

    Article  PubMed  CAS  Google Scholar 

  15. Wakefield J, Walker S (1998) Population models with a nonparametric random coefficient distribution. Sankhya Ser B 60:196–212

    Google Scholar 

  16. Mueller P, Rosner G (1997) A Bayesian population model with hierarchical mixture priors applied to blood count data. J Am Stat Assoc 92:1279–1292

    Google Scholar 

  17. Rosner G, Mueller P (1997) Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models. J Pharmacokinet Biopharm 25:209–233

    Article  PubMed  CAS  Google Scholar 

  18. Wang J (2010) Dirichlet processes in nonlinear mixed effects models. Commun Stat Simul Comput 39:539–556

    Article  Google Scholar 

  19. Yamada Y, Bartroff J, Bayard D, Burke J, Van Guilder M, RW J, et al. (2012) The nonparametric adaptive grid algorithm for population pharmacokinetic modeling. Technical Report, LAPK, USC, Laboratory of Applied Pharmacokinetics

  20. Neely M, Tatarinova T, Bartroff J, Van Guilder M, Yamada W, Bayard D, et al (2012) Non-parametric Bayesian fitting: a novel approach to population pharmacokinetic modeling. Poster presented at: Population Analysis Group in Europe, Venice

  21. Neely M, van Guilder M, Yamada W, Schumitzky A, Jelliffe R (2012) Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R. Ther Drug Monit 34(4):467–476

    Article  PubMed  Google Scholar 

  22. Bustad A, Terziivanov D, Leary R, Port R, Schumitzky A, Jelliffe R (2006) Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies. Clin Pharmacokinet 45(4):365–383

    Article  PubMed  Google Scholar 

  23. Ishwaran H, James L (2001) Gibbs sampling methods for stick-breaking priors. J Am Stat Assoc 96:161–173

    Article  Google Scholar 

  24. Jelliffe R, Bayard D, Milman M, Van Guilder M, Schumitzky A (2000) Achieving target goals most precisely using nonparametric compartmental models and “multiple model” design of dosage regimens. Ther Drug Monit 22:346–353

    Article  PubMed  CAS  Google Scholar 

  25. Schumitzky A (1991) Nonparametric EM algorithms for estimating prior distributions. Appl Math Comput 45:141–157

    Article  Google Scholar 

  26. Leary R, Jelliffe R, Schumitzky A, Van Guilder M (2001) An adaptive grid non-parametric approach to population pharmacokinetic/dynamic (PK/PD) population models. Proceedings, 14th IEEE symposium on computer based medical systems, pp 389–394

  27. Baek Y (2006) An interior point approach to constrained nonparametric mixture models. PhD Dissertation, Thesis supervisor: Prof. James Burke, University of Washington, Department of Mathematics

  28. Fox BL (1986) Algorithm 647: implementation and relative efficiency of Quasirandom sequence generators. Trans Math Softw 12(4):362–376

    Article  Google Scholar 

  29. Karush W (1939) Minima of functions of several variables with inequalities as side constraints. MSc disseertation, University of Chicago, Department of Mathematics, Chicago

  30. Kuhn H, Tucker A (1951) Nonlinear programming. Proceedings of the 2nd Berkeley Symposium, pp 481–492

  31. Papaspiliopoulos O, Roberts GO (2008) Retrospective Markov chain Monte Carlo methods for Dirichlet process hierarchical models. Biometrika 95(1):169–186

    Article  Google Scholar 

  32. Sethuraman J (1994) A constructive definition of Dirichlet priors. Statistica Sinica 4:639–650

    Google Scholar 

  33. Tatarinova T (2006) Bayesian analysis of linear and nonlinear mixture models. USC, Los Angeles

    Google Scholar 

  34. Tatarinova T, Bouck J, Schumitzky A (2008) Kullback-Leibler Markov chain Monte Carlo—a new algorithm for finite mixture analysis and its application to gene expression data. J Bioinform Comput Biol 6(4):727–746

    Article  PubMed  CAS  Google Scholar 

  35. Frühwirth-Schnatter S (2010) Finite mixture and markov switching models, 1st edn. Springer, New York

    Google Scholar 

  36. Ghosh P, Rosner G (2007) A semiparametric Bayesian approach to average bioequivalence. Stat Med 26:1224–1236

    Article  PubMed  Google Scholar 

  37. Ohlssen D, Sharples L, Spiegelhalter D (2007) Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons. Stat Med 26:2088–2112

    Article  PubMed  CAS  Google Scholar 

  38. Walker S (2007) Sampling the Dirichlet mixture model with slices. Commun Stat Simul Comput 36:45–54

    Article  Google Scholar 

  39. Kalli M, Griffen J, Walker S (2011) Slice sampling mixture models. Stat Comput 21:93–105

    Article  Google Scholar 

  40. Plummer M (2011) rjags: Bayesian graphical models using MCMC

  41. Robert C (2007) The Bayesian choice, 2nd edn. Springer, New York

    Google Scholar 

  42. Robert C, Casella G (2004) Monte Carlo statistical methods, 2nd edn. Springer, New York

    Book  Google Scholar 

  43. Dunson D (2010) Nonparametric Bayes applications to biostatistics. In: Hjort N, Holmes C, Muller P, Walker S (eds) Bayesian nonparametrics. Cambridge University Press, Cambridge, pp 223–268

Download references

Acknowledgments

Support from NIH: GM068968, EB005803, EB001978, NIH-NICHD: HD070996 and Royal Society: TG103083 is gratefully acknowledged.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tatiana Tatarinova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tatarinova, T., Neely, M., Bartroff, J. et al. Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian. J Pharmacokinet Pharmacodyn 40, 189–199 (2013). https://doi.org/10.1007/s10928-013-9302-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10928-013-9302-8

Keywords

Navigation